Research in COPD | ResMed

Research in COPD

Recent evidence indicates that treatment with home high-flow therapy (HFT) can have benefits for hypoxemic COPD patients,1,2 and that home non-invasive ventilation (NIV) can benefit hypercapnic COPD patients.3,4

References:

  1. Köhnlein T, et al., Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2014;2:698-705.
  2. Murphy P et al. Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation. A Randomized Clinical Trial, JAMA. Published online 21 May 2017. doi:10.1001/jama.2017.4451.
  3. Storgaard LH, et al. Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure. Int J Chron Obstruct Pulmon Dis 2018;13:1195-1205.
  4. Rea H, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010;104:525-533.

This content is intended for health professionals only. Please refer to the user (and clinical) guides for relevant information related to any warnings and precautions to be considered before and during use of the products.